Cite

    Hirotaka Watada et al.. “Pharmacokinetics and pharmacodynamics of dapagliflozin in combination with insulin in Japanese patients with type 1 diabetes.” Diabetes, obesity & metabolism, vol. 21, no. 4, 2019, pp. 876–882. http://access.bl.uk/ark:/81055/vdc_100078571506.0x000018